Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00012) | |||||
---|---|---|---|---|---|
Name |
Acitretin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Acitretin; 55079-83-9; Etretin; Soriatane; Neotigason; all-trans-Acitretin; Acitretine; Retinoid etretin; (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid; Acitretina; Acitretinum; Ro 10-1670; Ro 10-1670/000; UNII-LCH760E9T7; (all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid; all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid; CHEBI:50173; 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-; Ro-101670000; LCH760E9T7; 54757-46-9; NCGC00163127-02; Acitretine [French]; Acitretinum [Latin]; Acitretina [Spanish]; 2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-, (all-E)-; Soriatane CK; Soriatane (TN); CCRIS 5534; Ro-10-1670; 9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid; 9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid; HSDB 7187; EINECS 259-474-4; CHEBI:50172; Acitretin/; all-trans-Etretin; Acitretin [USAN:USP:INN:BAN]; Acitretin,(S); Acitretin (USP/INN); Spectrum5_002065; DSSTox_CID_2553; Ro-10-1670/000; SCHEMBL3759; CHEMBL1131; DSSTox_RID_76624; DSSTox_GSID_22553; MLS001076667; BIDD:GT0617; GTPL7598; DTXSID6022553; BCPP000437; HMS2234L17; HMS3259J12; HMS3714E17; 2-Ethynyl-5-Methylpyridine1-oxide; Acitretin, >=98.0% (HPLC); HY-B0107; ZINC3798734; Tox21_112012; ABP000589; BDBM50088429; MFCD00866632; STL565770; AKOS015889991; AB07538; AC-4702; BCP9000229; CCG-220668; CS-1855; DB00459; KS-5246; NC00723; 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-; NCGC00163127-01; NCGC00163127-03; (2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid; (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoic acid; (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid; AS-12644; SMR000499573; AB0007949; CAS-55079-83-9; SW199134-2; D02754; AB00698376-08; AB00698376_09; Acitretin 100 microg/mL in Acetonitrile:Acetone; 079A839; A830475; Q341500; SR-01000763200; SR-01000763200-3; BRD-K90699611-001-01-4; Acitretin, British Pharmacopoeia (BP) Reference Standard; Acitretin, European Pharmacopoeia (EP) Reference Standard; Acitretin, United States Pharmacopeia (USP) Reference Standard; Acitretin, Pharmaceutical Secondary Standard; Certified Reference Material; 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Psoriasis vulgaris | ICD-11: EA90 | [1] | ||
PubChem CID | |||||
Formula |
C21H26O3
|
||||
Canonical SMILES |
CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC
|
||||
InChI |
1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+
|
||||
InChIKey |
IHUNBGSDBOWDMA-AQFIFDHZSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5284513"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 326.4 | Topological Polar Surface Area | 46.5 | |
XlogP | 6.1 | Complexity | 539 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 6 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Acitretin 25 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Fd&c yellow no. 6; Indigotindisulfonate sodium; Sodium ascorbate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Poloxamer 188; Crospovidone (15 mpa.s at 5%); Gelatin, unspecified; Microcrystalline cellulose; Povidone k90; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide yellow; Titanium dioxide; Povidone; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide yellow; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Povidones
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AvKARE | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Poloxamer 407; Gelatin, unspecified; Microcrystalline cellulose; Povidone, unspecified; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Stiefel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Gelatin, unspecified; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Capsule | |||||
Company | GlaxoSmithKline; Prasco | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Acitretin 17.5 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Poloxamer 188; Crospovidone (15 mpa.s at 5%); Gelatin, unspecified; Microcrystalline cellulose; Povidone k90; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Poloxamer 188; Aluminum oxide; Cellulose, microcrystalline; Gelatin; Povidone k90; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [5] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Povidone; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Povidones
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AvKARE | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Stiefel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Gelatin, unspecified; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Capsule | |||||
Company | GlaxoSmithKline | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Acitretin 10 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Sodium ascorbate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Poloxamer 188; Crospovidone (15 mpa.s at 5%); Gelatin, unspecified; Microcrystalline cellulose; Povidone k90; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 188 | DIG Info | Albendazole monooxygenase (IC50 = 60 uM) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide yellow; Titanium dioxide; Povidone; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sigmapharm Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Maltodextrin; Sodium ascorbate; Ferric oxide yellow; Titanium dioxide; Cellulose, microcrystalline; Gelatin; Povidones
|
|||||
Dosage Form | Oral Capsule | |||||
Company | AvKARE | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [3] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ammonia; Edetate disodium; Ferric oxide red; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Poloxamer 407; Gelatin, unspecified; Microcrystalline cellulose; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Poloxamer 407 | DIG Info | Albendazole monooxygenase (EC50 = 32.8 uM) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Stiefel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Gelatin, unspecified; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Capsule | |||||
Company | GlaxoSmithKline; Prasco | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Acitretin 22.5 mg capsule | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferrosoferric oxide; Propylene glycol; Cellulose, microcrystalline; Gelatin; Shellac
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Actavis Pharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Maltodextrin; Sodium ascorbate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Titanium dioxide; Cellulose, microcrystalline; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Stiefel Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.